BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19858775)

  • 1. Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia.
    Ziino AJ; Ivanovska J; Belcastro R; Kantores C; Xu EZ; Lau M; McNamara PJ; Tanswell AK; Jankov RP
    Pediatr Res; 2010 Feb; 67(2):177-82. PubMed ID: 19858775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
    Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
    Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
    Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho-kinase inhibitor prevents bleomycin-induced injury in neonatal rats independent of effects on lung inflammation.
    Lee AH; Dhaliwal R; Kantores C; Ivanovska J; Gosal K; McNamara PJ; Letarte M; Jankov RP
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):61-73. PubMed ID: 23947621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho-kinase inhibitor Y-27632 attenuates pulmonary hypertension in hyperoxia-exposed newborn rats.
    Chou HC; Huang LT; Yeh TF; Chen CM
    Acta Pharmacol Sin; 2013 Oct; 34(10):1310-6. PubMed ID: 23974518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide.
    McNamara PJ; Murthy P; Kantores C; Teixeira L; Engelberts D; van Vliet T; Kavanagh BP; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L205-13. PubMed ID: 18032699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Src tyrosine kinases in experimental pulmonary hypertension.
    Pullamsetti SS; Berghausen EM; Dabral S; Tretyn A; Butrous E; Savai R; Butrous G; Dahal BK; Brandes RP; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Rosenkranz S; Schermuly RT
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1354-65. PubMed ID: 22516066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.
    Gosal K; Dunlop K; Dhaliwal R; Ivanovska J; Kantores C; Desjardins JF; Connelly KA; McNamara PJ; Jain A; Jankov RP
    Am J Respir Cell Mol Biol; 2015 Jun; 52(6):717-27. PubMed ID: 25337652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of phosphatidylinositol 3-kinase/Akt signaling attenuates hypoxia-induced pulmonary artery remodeling and suppresses CREB depletion in arterial smooth muscle cells.
    Garat CV; Crossno JT; Sullivan TM; Reusch JE; Klemm DJ
    J Cardiovasc Pharmacol; 2013 Dec; 62(6):539-48. PubMed ID: 24084215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling.
    Wong MJ; Kantores C; Ivanovska J; Jain A; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L985-L999. PubMed ID: 27694473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained therapeutic hypercapnia attenuates pulmonary arterial Rho-kinase activity and ameliorates chronic hypoxic pulmonary hypertension in juvenile rats.
    Peng G; Ivanovska J; Kantores C; Van Vliet T; Engelberts D; Kavanagh BP; Enomoto M; Belik J; Jain A; McNamara PJ; Jankov RP
    Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2599-611. PubMed ID: 22505643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats.
    Qi XJ; Ning W; Xu F; Dang HX; Fang F; Li J
    Int J Clin Exp Pathol; 2015; 8(10):12140-50. PubMed ID: 26722398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Rho kinase and Na+/H+ exchange in hypoxia-induced pulmonary arterial smooth muscle cell proliferation and migration.
    Walker J; Undem C; Yun X; Lade J; Jiang H; Shimoda LA
    Physiol Rep; 2016 Mar; 4(6):. PubMed ID: 27009277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in pulmonary and systemic vascular beds in the rat.
    Pankey EA; Thammasiboon S; Lasker GF; Baber S; Lasky JA; Kadowitz PJ
    Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1288-96. PubMed ID: 23997103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent rho-kinase and tyrosine kinase platelet-derived growth factor inhibition in experimental pulmonary hypertension.
    Jasińska-Stroschein M; Owczarek J; Plichta P; Orszulak-Michalak D
    Pharmacology; 2014; 93(3-4):145-50. PubMed ID: 24662671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for platelet-derived growth factor beta-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling.
    Jankov RP; Kantores C; Belcastro R; Yi S; Ridsdale RA; Post M; Tanswell AK
    Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1162-70. PubMed ID: 15722379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
    Li FH; Xia W; Li AW; Zhao CF; Sun RP
    Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel inhibitor of inducible nitric oxide synthase, ONO-1714, does not ameliorate hypoxia-induced pulmonary hypertension in rats.
    Jiang BH; Maruyama J; Yokochi A; Mitani Y; Maruyama K
    Lung; 2007; 185(5):303-308. PubMed ID: 17721804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1-Rho kinase interactions impair lung structure and cause pulmonary hypertension after bleomycin exposure in neonatal rat pups.
    Gien J; Tseng N; Seedorf G; Kuhn K; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1090-L1100. PubMed ID: 27760762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.